Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Appointed director
Myrexis, Inc. (MYRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/29/2013 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment of Certificate of Incorporation to Implement the Protective Amendment"
04/18/2013 8-K Quarterly results
03/05/2013 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
02/28/2013 8-K Other Events
02/20/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/21/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
08/21/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Myrexis Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate"
08/10/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Letter Agreement by and among Myrexis, Inc., Bulldog Investors and Brooklyn Capital Management LLC",
"Letter Agreement by and among Myrexis, Inc., MSMB Healthcare LP, MSMB Healthcare Investors LLC, MSMB Healthcare Management LLC and MSMB Capital Management LLC",
"Letter Agreement by and between Myrexis, Inc. and Martin Shkreli"
05/11/2012 8-K Form 8-K - Current report
03/30/2012 8-K Form 8-K - Current report
02/16/2012 8-K Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits
Docs: "Myrexis Retains Investment Bank to Explore Strategic Alternatives"
12/14/2011 8-K Form 8-K - Current report
11/18/2011 8-K Form 8-K - Current report
10/21/2011 8-K Form 8-K - Current report
09/12/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Offer Letter by and between Myrexis, Inc. and Robert J. Lollini",
"First Amendment, to Executive Severance and Change in Control Agreement by and between Myrexis, Inc. and Robert J. Lollini",
"Myrexis Board of Directors Appoints Robert Lollini CEO"
09/08/2011 8-K Quarterly results
Docs: "Myrexis Reports Fourth Quarter and Fiscal Year 2011 Results"
07/22/2011 8-K Form 8-K - Current report
03/29/2011 8-K Form 8-K - Current report
11/15/2010 8-K Form 8-K - Current report
09/09/2010 8-K Form 8-K - Current report
07/01/2010 8-K Form 8-K - Current report
06/10/2010 8-K Form 8-K - Current report
06/09/2010 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "First Amendment, to Executive Severance and Change in Control Agreement by and between Myriad Pharmaceuticals, Inc. and Barbara Berry",
"Myriad Pharmaceuticals Announces Intent to Focus on Oncology Portfolio",
"Myriad Pharmaceuticals Announces Presentations of Phase 2 Data of Azixa TM Demonstrating Durable Responses in Patients with Glioblastoma Multiforme and Metastatic Melanoma at ASCO 2010"
04/23/2010 8-K Submission of Matters to a Vote of Security Holders
04/19/2010 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Myriad Pharmaceuticals Announces Termination of Merger Agreement with Javelin Pharmaceuticals"
04/12/2010 8-K Form 8-K - Current report
03/15/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Myriad Pharmaceuticals, Inc. Sets Date for Special Stockholder Meeting to Approve Merger with Javelin Pharmaceuticals, Inc."
03/10/2010 8-K Acquisition/merger/asset purchase announced
Docs: "First Amendment, to the Loan and Security Agreement, by and among Myriad Pharmaceuticals, Inc., Javelin Pharmaceuticals, Inc., and Innovative Drug Delivery Systems, Inc"
02/16/2010 8-K Form 8-K - Current report
02/04/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Severance and Change in Control Agreement by and between Myriad Pharmaceuticals, Inc. and Adrian N. Hobden",
"Form of Executive Severance and Change in Control Agreement entered into between Myriad Pharmaceuticals, Inc. and the Executive Officers of Myriad Pharmaceuticals, Inc. listed on Schedule I attached thereto, on February 1, 2010"
02/03/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th"
02/02/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject™ - Key Milestone in the Proposed Merger of Myriad Pharmaceuticals and Javelin Pharmaceuticals -"
01/14/2010 8-K Other Events
12/18/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Myriad Pharmaceuticals, Inc., MPI Merger Sub, Inc., Javelin Pharmaceuticals, Inc., and the Stockholder Representative",
"Form of Escrow Agreement by and among Myriad Pharmaceuticals, Inc., the Escrow Agent, and the Stockholder Representative, to be entered into at or prior to consummation of the Merger",
"Form of Javelin Stockholder Voting Agreement and a schedule of signatories thereto",
"Form of MPI Stockholder Voting Agreement and a schedule of signatories thereto",
"Loan and Security Agreement, by and among Myriad Pharmaceuticals, Inc., Javelin Pharmaceuticals, Inc., and Innovative Drug Delivery Systems, Inc",
"Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals - Creates pipeline with potential near-term product launch of Dyloject™ and portfolio of early-, mid- and late-stage drug candidates in cancer, HIV and pain - -Joint Conference Call Scheduled for 9:00 AM ET Friday, December 18, 2009 -"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy